Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

WIC reauthorization bill expected to reach House floor before July 4 recess.

This article was originally published in The Tan Sheet

Executive Summary

WIC REAUTHORIZATION TO REACH HOUSE FLOOR BEFORE JULY 4 RECESS under the current plan for HR 3874, the "WIC Reauthorization Amendments of 1998," which passed the House Committee on Education and the Workforce by a vote of 36-1 June 4. As reported out by the committee, HR 3874 has been merged with legislation reauthorizing other child nutrition programs, including the summer, after school and breakfast food programs. The bill would reauthorize the Women, Infants & Children federal assistance program, which provides infant formula and other food to needy children and mothers, through 2003. The Independence Day congressional recess is scheduled to begin in the House June 26.

You may also be interested in...



Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

People In Brief

Perrigo promotes in pricing, planning

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS088548

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel